跳至主要内容
临床试验/NCT00264173
NCT00264173已完成4 期

A Twelve-Week, Open, Randomized Trial Comparing Valproate to Lithium in Bipolar I Patients Suffering From a Manic Episode

Sanofi0 个研究点目标入组 270 人开始时间: 2004年2月最近更新:
适应症
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
Sanofi
入组人数
270
主要终点
Change from baseline to D END in the Young Mania Rating Scale total score

研究概览

简要总结

Primary Objective :

  • To compare the efficacy of valproate to lithium in Bipolar I patients suffering from a manic or a mixed episode according to DSM IV TR (APA 2000) [Diagnostic and Statistical Manual of Mental Disorders (DSM) fourth edition (IV)Text Revision (TR)] and over a periode of 3 weeks and 12 weeks of treatment

Secondary Objective :

  • To evaluate the clinical and biological safety of valproate compared to lithium.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Change from baseline to D END in the Young Mania Rating Scale total score

次要结局

  • Change from baseline to each assessment in the YMRS score
  • Percentage of responders defined by a decrease of at least 50% in the YMRS score between D0 and D END
  • Percentage of responders at week 3 defined by a decrease of at least 50 % in the YMRS score between D0 and D21
  • Change in the Clinical Global Impressions Scale for Bipolar Disorder (CGI-BP) (20) between D0 and D21
  • Change in the CGI-BP between D0 and D END
  • Change in the MADRS between D0 and D21 (MADRS: Montgomery and Asberg Depression Rating Scale )
  • Change in the MADRS between D0 and D END
  • Survival analyses: Time to achieve 50% and 30% improvement in the YMRS score; Time to antidepressant intake; Time to drop-out for any reason.

研究者

发起方
Sanofi
申办方类型
Industry

相似试验